Genetic disorders of keratins and their associated proteins

Journal of Dermatological Science

Volumn 13, Issue 3, 1996, Pages 181-192

  Fuchs, Elaine ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

epidermolysis bullosa simplex; genetic disorders; keratin

Indexed keywords

KERATIN;

EPIDERMOLYSIS BULLOSA SIMPLEX; GENETIC DISORDER; HUMAN; NAIL DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; GENETICS;

ANIMALS; GENETIC DISEASES, INBORN; HUMANS; KERATINS;

EID: 0030483921     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00568-3     Document Type: Article

References (105)

1. [1] Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63: 345-382, 1994.
2. [2] Fuchs E: Keratins: mechanical integrators in the epidermis and hair and their role in disease. Prog Dermatol 30: 1-12, 1996.
3. [3] Moll R, Franke WW, Schiller DL, Geiger B, Krepier R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors, and cultured cells. Cell 31: 11-24, 1982
4. [4] Fuchs E, Coppock S, Green H, Cleveland D: Two distinct classes of keratin genes and their evolutionary significance. Cell 27: 75-84, 1981.
5. [5] Hanukoglu I, Fuchs E: The cDNA sequence of a type II cytoskeletal keratin reveals constant and variable structural domains among keratins. Cell 33: 915-924, 1983.
6. [6] Sun T-T, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss RA: The Transformed Phenotype, in: The Cancer Cell, Vol. 1. (Edited by A Levine, W Topp, G Woude, JD van de Watson. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1984, pp. 169-176.
7. [7] Nelson W, Sun T-T: The 50-and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol 97: 244-251, 1983.
8. [8] Fuchs E, Green H: Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19: 1033-1042, 1980.
9. [9] Stoler A, Kopan R, Duvic M, Fuchs E: The use of monospecific antibodies and cRNA probes reveals abnormal pathways of terminal differentiation in human epidermal diseases. J Cell Biol 107: 427-446, 1988.
10. [10] Collin C, Moll R, Kubicka S, Ouhayoun JP, Franke WW: Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res 202: 132-141, 1992.
11. [11] Langbein L, Heid HW, Moll I, Franke WW: Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation 55: 57-71, 1993.
12. [12] Coulombe PA, Kopan R, Fuchs E: Expression of keratin K14 in the epidermis and hair follicle: insights into complex programs of differentiation. J Cell Biol 109: 2295-2312, 1989.
13. [13] Mansbridge JN, Knapp AM: Changes in keratinocyte maturation during wound healing. J Invest Derm 89: 253-262, 1987.
14. [14] Choi Y, Fuchs E: TGF-beta and retinoic acid: regulators of growth and modifyers of differentiation in human epidermal cells. Cell Regul 1: 791-809, 1990.
15. [15] Stark H-J, Breitkreutz D, Limat A, Bowden P, Fusenig NE: Keratins of the human hair follicle: 'hyperproliferative' keratins consistently expressed in outer root sheath cells in vivo and in vitro. Different 35: 236-248, 1987.
16. [16] Lynch MH, O'Guin WM, Hardy C, Mak L, Sun T-T: Acidic and basic hair/nail ('hard') keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to 'soft' keratins. J Cell Biol 103: 2593-2606, 1986.
17. [17] Steinert PM, Rice DRR, Trus ACS: Complete amino acid sequence of a mouse epidermal keratin subunit and implications for the structure of intermediate filaments. Nature 302: 794-800, 1983.
18. [18] Kouklis P, Hutton E, Fuchs E: Making the connection: keratin intermediate filaments and desmosomes proteins. J Cell Biol 127: 1049-1060, 1994.
19. [19] Dale BA, Holbrook KA, Steinert PM: Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature 276: 729-731, 1978.
20. [20] Steinert PM, Marekov LN, Fraser RDB, Parry DAD: Keratin intermediate filament structure: crosslinking studies yield quantitative information on molecular dimensions and mechanisms of assembly. J Mol Biol 230: 436-452, 1993.
21. [21] Powell BC, Rogers GE: Cyclic hair-loss and regrowth in transgenic mice overexpressing an intermediate filament gene. EMBO J.
22. [22] Steinert PM, Idler WW, Zimmerman SB: Self-assembly of bovine epidermal keratin filaments in vitro. J Mol Biol 108: 547-567, 1976.
23. [23] Franke WW, Schiller DL, Hatzfeld M, Winter S: Protein complexes of intermediate-sized filaments: melting of cytokeratin compexes in urea reveals different polypeptide separation characteristics, Proc Natl Acad Sci USA 80: 7113-7117, 1983.
24. [24] Coulombe P, Fuchs E: Elucidating the early stages of keratin filament assembly. J Cell Biol 111: 153-169, 1990.
25. [25] Hatzfeld M, Weber K: Tailless keratins assemble into regular intermediate filaments in vitro. J Cell Sci 97: 317-324, 1990.
26. [26] Steinert PM: The two-chain coiled-coil molecular of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 265: 8766-8774, 1990.
27. [27] Conway JF, Parry DAD: Intermediate filament structure. 3. Analysis of sequence homologies. Int J Biol Macromol 10: 79-98, 1988.
28. [28] Albers K, Fuchs E: The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J Cell Biol 105: 791-806, 1987.
29. [29] Albers K, Fuchs E: Expression of mutant keratin cD-NAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. J Cell Biol 108: 1477-1493, 1989.
30. [30] Lu X, Lane EB: Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: specific domain functions in keratin stabilization and filament formation. Cell 62: 681-696, 1990.
31. [31] Hatzfeld M, Weber K: Modulation of keratin intermediate filament assembly by single amino acid exchanges in the consensus sequence at the C-terminal end of the rod domain. J Cell Sci 99: 351-362, 1990.
32. [32] Coulombe PA, Hutton ME, Vassar R, Fuchs E: A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J Cell Biol 115: 1661-1674, 1991.
33. [33] Wilson AK, Coulombe PA, Fuchs E: The roles of K5 and K14 head, tail and R/KLLEGE domains in keratin filament assembly in vitro. J Cell Biol 119: 401-414, 1992.
34. [34] Letai A, Coulombe P, Fuchs E: Do the ends justify the mean? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations. J Cell Biol 116: 1181-1195, 1992.
35. [35] Hanukoglu I, Fuchs E: The cDNA sequence of a human epidermal keratin: divergence of sequence but conservation of structure among intermediate filament proteins. Cell 31: 243-252, 1982.
36. [36] Steinert PM, Parry DAD: The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two-to four-molecule level of structure. J Biol Chem 268: 2878-2887, 1993.
37. [37] Aebi U, Cohn JB, Gerace LL: The nuclear lamina is a meshwork of intermediate-type filaments. Nature 323: 560-564, 1986.
38. [38] Hatzfeld M, Weber K: A synthetic peptide representing the consensus sequence motif at the carboxy-terminal end of the rod domain inhibits intermediate filament assembly and disassembles preformed filaments. J Cell Biol 116: 157-166, 1992.
39. [39] Aebi U, Fowler WE, Rew P, Sun T-T: The fibrillar substructure of keratin filaments unraveled. J Cell Biol 97: 1131-1143, 1983.
40. [40] Steven A, Hainfeld J, Trus B, Wall J, Steinert P: Epidermal keratin filaments assembled in vitro have masses-per-unit length that scale according to average subunit mass: structural basis for homologous packing of subunits in intermediate filaments. J Cell Biol 97: 1939-1944, 1983.
41. [41] Coulombe P, Chan YM, Albers K, Fuchs E: Deletions in epidermal keratins leading to alterations in filament organization in vivo and in intermediate filament assembly in vitro. J Cell Biol 111: 3049-3064, 1990.
42. [42] Vassar R, Coulombe PA, Degenstein L, Albers K, Fuchs E: Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 64: 365-380, 1991.
43. [43] Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E: Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 66: 1301-1311, 1991.
44. [44] Fuchs E, Esteves RA, Coulombe PA: Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 89: 6906-6910, 1992.
45. [45] Anton-Lamprecht I: Ultrastructural identification of basic abnormalities as clues to genetic disorders of the epidermis. J Invest Dermatol 103: 65-125, 1994.
46. [46] Anton-Lamprecht I, Schnyder VW: Epidermolysis bullosa herpetiformis Dowling-Meara: report of a case and pathogenesis. Dermatology 164: 221-235, 1982.
47. [47] Kitajima Y, Inoue S, Yaoita H: Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex. Arch Dermatol Res 281: 5-10, 1989.
48. [48] Bonifas JM, Rothman AL, Epstein EH: Epidermolysis butlosa simplex: evidence in two families for keratin gene abnormalities. Science 254: 1202-1205, 1991.
49. [49] Rosen berg M, RayChaudhury A, Shows TB, LeBeau MM, Fuchs E: A group of type I keratin genes on human chromosome 17: characterization and expression. Mol Cell Biol 8: 722-736, 1988.
50. [50] Rosenberg M, Fuchs E, Le Beau MM, Eddy R, Shows TB: Three epidermal and one epithelial keratin gene map to human chromosome 12. Cell Cytogenet 57: 33-38, 1991.
51. [51] Cooper DN, Youssoufian H: The CpG dinucleotide and human genetic disease. Hum Genet 78: 151-155, 1988.
52. [52] Stephens K, Sybert VP, Wijsman EM, Ehrlich P, Spencer A: A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling-Meara: implications for diagnosis. J Invest Dermatol 101: 240-243, 1993.
53. [53] Chen H, Bonifas JM, Matsumura K, Ikeda S, Leyden WA: Keratin 14 gene mutations in patients with epidermolysis bullosa simplex. J Invest Dermatol 105: 629-632, 1995.
54. [54] Chan YM, Cheng J, Gedde-Dahl T, Niemi KM, Fuchs E: Genetic analysis of a severe case of dowling-meara epidermolysis bullosa simplex. J Invest Dermatol 3106: 327-334, 1996.
55. [55] Dodemont H, Riemer D. Weber K: Structure of an invertebrate gene encoding cytophsmic intermediate filament (IF) proteins: implications from the origin and the diversification of IF proteins. EMBO J 9: 4083-4094, 1990.
56. [56] Lane EB, Rugg EL, Navsaria H, Leigh IM, Heagerty AHM, Ishida-Yamamoto A, Eady RAJ: A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 356: 244-246, 1992.
57. [57] Chan YM, Yu QC, Fine JD, Fuchs E: The genetic basis of Weber-cockayne epidermolysis bullosa simplex. Proc Natl Acad Sci USA 90: 7414-7418, 1993.
58. [58] Chan YM, Yu QC, LeBlanc-Straceski J, Christiane A, Pulkkinen L, Kucherlapati RS, Uitto J, Fuchs E: Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex. J Cell Sci 107: 765-774, 1994.
59. [59] Rugg EL, Morley SM, Smith FJD, Boxer M, Tidman MJ, Navsaria H, Leigh IM, Lane EB: Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function. Nat Genet 5: 294-300, 1993.
60. [60] Hovnanian A, Pollack E, Hilal L, Rochat A, Prost C, Barrandon Y, Goosens MA: A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat Genet 3: 327-332, 1993.
61. [61] Dong W. Ryynanen M, Uitto J: Identification of a leucine-to-proline mutation in the keratin 5 gene in a family with the generalized kobner type of epidermolysis bullosa simplex (EBS). Hum Mutat 2: 94-102, 1993.
62. [62] Humphries MM, Sheils DM, Farrar GJ, Kumar-Singh R, Kenna PF, Mansergh FC, Jordan SA, Young M, Humphries P: A mutation (Met → Arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex. Hum Mutat 2: 37-42, 1993.
63. [63] Yamanishi K, Matsuki M, Konishi K, Yasuno H: A novel mutation of leu122 to Phe at a highly conserved hydrophobic residue in the helix initiation motif of keratin 14 in epidermolysis bullosa simplex. Hum Mol Genet 3: 1171-1172, 1994.
64. [64] Ehrlich P, Sybert VP, Spencer A, Stephens K: A common keratin 5 gene mutation in epidermolysis bullosa simplex - Weber-Cockayne. J Invest Dermatol 104: 877-879, 1995.
65. [65] Letai A, Coulombe PA, McCormick MB, Yu QC, Hutton E, Fuchs E: Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. Proc Natl Acad Sci USA 90: 3197-3201, 1993.
66. [66] Uttam J, Hutton E, Coulombe P, Anton-Lamprecht I, Yu QC, Gedde-Dahl T, Fine JD, Fuchs E: The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci USA, 1996 (in press).
67. [67] Haneke E, Anton-Lamprecht I: Ultrastructure of blister formation in epidermolysis bullosa hereditaria. V. Epidermolysis bullosa simplex localisata type Weber-Cockayne. J Invest Dermatol 78: 219-223, 1982.
68. [68] Compton JG, DiGiovanna JJ, Santucci SK, Kearns KS, Amos CI, Abangan DL, Korge BP, McBride OW, Steinert PM, Bale SJ: Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q. Nat Genet 1: 301-305, 1992.
69. [69] Rothnagel JA, Dominey AM, Dempsey LD, Longley MA, Greenhalgh DA, Gagne TA, Huber M, Frenk E, Hohl D, Roop DR: Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 257: 1128-1130, 1992.
70. [70] Cheng J. Syder AJ, Yu QC, Letai A, Paller AS, Fuchs E: The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 70: 811-819, 1992.
71. [71] Chipev CC, Korge BP, Markova N, Bale SJ, DiGiovanna JJ, Compton JG, Steinert PM: A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 70: 821-828, 1992.
72. [72] Rothnagel JA, Longley MA, Holder RA, Bundman DS, Seki T, Bickenbach JR, Roop DR: Genetic disorders of keratin: are scarring alopecias a sub-set? J Dermatol Sci 7: S164-169, 1994.
73. [73] Syder AJ, Yu QC, Paller AS, Giudice G, Pearson R, Fuchs E: Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis: correlation between location and disease severity. J Clin Invest 93: 1533-1542, 1994.
74. [74] Chipev CC, Yang JM, DiGiovanna JJ, Steinert PM, Marekov L, Compton JG, Bale SJ: Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 54: 179-190, 1994.
75. [75] Yang JM, Chipev CC, DiGiovanna JJ, Bale SJ, Marekov LN, Steinert PM, Compton JG: Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. J Invest Dermatol 102: 17-23, 1994.
76. [76] McLean WH, Eady RA, Dopping-Hepenstal PJ, McMillan JR, Leigh IM, Navsaria HA, Higgins C, Harper JI, Paige DG, Morley SM: Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichtyosiform erythroderma (BCIE). J Invest Dermatol 102: 24-30, 1994.
77. [77] McLean WH, Morley SM, Lane EB, Eady RA, Griffiths WA, Paige DG, Harper JI, Higgins C, Leigh IM: Ichthyosis bullosa of Siemens - a disease involving keratin 2e. J Invest Dermatol 103: 277-281, 1994.
78. [78] Kremer H, Zeeuwen P, McLean WH, Mariman EC, Lane EB, van de Kerkhof CM. Ropers HH, Steijlen PM: Ichthyosis bullosa of Siemens is caused by mutations in the keratin 2e gene. J Invest Dermatol 103: 286-289, 1994.
79. [79] Paller AS, Syder AJ, Chan YM, Yu QC, Hutton E, Tadini G, Fuchs E: A direct link between clinical and genetic mosaicism: the genetic basis of a form of epidermal nevus. N Engl J Med 331: 1408-1415, 1994.
80. [80] Torchard D. Blanchet-Bardon C, Serova O, Langbein L, Narod S, Janin N, Goguel AF, Bernheim A, Franke WW, Lenoir GM, Feunteun J: Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet 6: 106-109, 1994.
81. [81] Reis A, Hennies HC, Langbein L, Digweed M, Mischke D, Drechsler M, Schrock E, Royer-Pokora B, Franke W, Sperling K, Kuster W: Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 6: 174-179, 1994.
82. [82] Hennies HC, Zehender D, Kunze J, Kuster W, Reis A: Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 93: 649-654, 1994.
83. [83] Rothnagel JA, Wojcik S, Liefer KM, Dominey AM, Huber M, Hohl D, Roop DR: Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. J Invest Dermatol 104: 430-433, 1995.
84. [84] Kimonis V, Giovanna JJ, Yang JM, Doyle SZ, Bale SJ, Compton JG: A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol 103: 764-769, 1994.
85. [85] Steinert PM, Marekov LN: Efafin, filaggrin, keratin IFs, loricrin and small proline-rich proteins 1 and 2 are crosslinked components of the cornified envelope. J Biol Chem 270: 17702-17711, 1995.
86. [86] Allen E, Yu QC, Fuchs E: Abnormalities in desmosomes, proliferation and differentiation in the epidermis of mice expressing a mutant desmosomal cadherin. J Cell Biol 133: 1367-1382, 1996.
87. [87] Munro CS, Carter S, Bryce S, Hall M, Rees JL, Kunkeler L, Stephenson A, Strachan T: A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-q21. J Med Genet 31: 675-678, 1994.
88. [88] Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ: Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 10: 363-365, 1995.
89. [89] Richard G, DeLaurenzi V, Didona B, Bale SJ, Compton JG: Keratin 13 point mutation underlies the hereditary mucosal epithelia disorder white sponge nevus. Nat Genet 11: 453-455, 1995.
90. [90] Rugg EL, McLean WHI, Allison WE, Lunny DP, Macleod RI, Felix DH, Lane EB, Munro CS: A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet 11: 450-452, 1995.
91. [91] Garrod DR: Desmosomes and hemidesmosomes. Curr Opin Cell Biol 5: 30-40, 1993.
92. [92] Stepp MA, Spurr-Michaud S, Tisdale A, Elwell J, Gipson IK: Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA 87: 8970-8974, 1990.
93. [93] Giudice GJ, Squiquera HL, Elias PM, Diaz LA: Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest 87: 734-738, 1991.
94. [94] Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53: 291-325, 1993.
95. [95] Dowling J, Yu QC, Fuchs E: Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol, 1996 (in press).
96. [96] Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Uitto J: Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 6: 293-297, 1994.
97. [97] Pulkkinen L, Christiano AM, Gerecke DR, Wagman DW, Burgeson RE, Pittelkow MR, Uitto J: A homozygous nonsense mutation in the beta3 chain gene of laminin 5 (LAMB3) in Herlitz's junctional epidermolysis bullosa. Genomics 24: 357-360, 1994.
98. [98] Aberdam D, Galliano MF, Vailly J, Pulkkinen L, Bonifas J, Christiano AM, Tryggvason K, Uitto J, Epstein EHJ, Ortonne JP: Herlitz's junctional epidermolysis bullosa is genetically linked to mutations in the nicein/ kalinin (laminin 5) LAMC2 gene. Nat Genet 6: 299-304, 1994.
99. [99] Kivirikko S, McGrath JA, Baudoin C, Aberdam D, Ciatti S, Dunnill MGS, McMillan JR, Eady RAJ, Ortonne JP, Meneguzzi G, Uitto J, Christiano AM: A homozygous nonsense mutation in the alpha3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 4: 959-962, 1995.
100. [100] Christiano AM, Pulkkinen L, Eady RAJ, Uitto J: Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol 106: 775-777, 1996.
101. [101] McGrath JA, Kivirikko S, Ciatti S, Moss C, Christiano AM, Uitto J: A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz's junctional epidermolysis bullosa in patients of Pakistani ancestry: evidence for a founder effect. J Invest Dermatol 106: 781-784, 1996.
102. [102] Vidai F, Aberdam D, Miquel C, Christiano AM, Pulkkinen L, Uitto J, Ortonne JP, Meneguzzi G: Integrin beta4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 10: 229-234, 1995.
103. [103] Guo L, Degenstein L, Dowling J, Yu QC, Wollmann R, Perman B, Fuchs E: Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified squamous epithelia and severe neurologic degeneration. Cell 81: 233-243, 1995.
104. [104] Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, Fuchs E: An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell, 1996 (in press).
105. [105] Foisner R, Feldman B, Sander L, Wiche G: Monoclonal antibody mapping of structural and functional plectin epitopes. J Cell Biol 112: 397-405, 1991.